Skip to main navigation
Skip to content
Opiant_logo Opiant
Main Menu
  • Contact
  • Careers
  • About
    • Corporate Overview
    • Management Team
    • Board of Directors
    • Medical Advisory Board
    • Media
    • Careers
  • Addiction Disorders
    • Opioid Use Disorder
    • Alcohol Use Disorder
    • Acute Cannabinoid Overdose
    • Patients & Families
    • Scientific Publications
  • Products & Pipeline
    • Pipeline Chart
  • Investors
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • News Releases
    • Events and Presentations
    • Corporate Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Financials & Filings
      • SEC Filings
      • Quarterly Results
      • Annual Reports & Proxy Statements

Investors

SEC Filing Details

SEC Filing Details

Document Details

Form
DEFA14A
Filing Date
Nov 15, 2022
Document Date
Nov 15, 2022
Form Description
Additional proxy soliciting materials - definitive
Filing Group
Proxy Filings
Company
Opiant Pharmaceuticals, Inc.
Issuer
OPIANT PHARMACEUTICALS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS
Print Page
RSS Feeds
Email Alerts
Contact IR

  • Privacy Policy
  • Site Map
© Opiant, 2023. All Rights Reserved.